Showing 291-300 of 19172 results for "".
Musculoskeletal Aspects of MPS I: Diagnosis and Management Considerations
https://reachmd.com/programs/clinicians-roundtable/musculoskeletal-aspects-of-mps-i-diagnosis-and-management-considerations/4758/What are the musculoskeletal signs and symptoms in children with MPS I? How can we test for MPS I? And how does the disease present in patients as they grow up? Dr. Gregory M. Pastores, associate professor of neurology and pediatrics at the New York University School of Medicine in New York, and dirPedophilia -Types and Classifications
https://reachmd.com/programs/clinicians-roundtable/pedophilia-types-and-classifications/408/Dr. Ryan Hall, a senior resident from the Department of Psychiatry and Behavioral Sciences at John Hopkins University defines pedophilia and classifies distinctions between the different types.Biomolecular Advances in Diabetes Prevention
https://reachmd.com/programs/focus-on-diabetes/biomolecular-advances-in-diabetes-prevention/6098/As the epidemic of type 2 diabetes in the United States grows, researchers are investigating hundreds of ways to treat and cure diabetes. Some of these methods include exogenous insulin, while other ideas being explored require more complex changes in our understanding of cellular biology. Dr. CarmeDecoding Diabetes Diversity: A Study on Heterogeneity and Endotypes in T1D
https://reachmd.com/programs/diabetes-discourse/decoding-diabetes-diversity-a-study-on-heterogeneity-and-endotypes-in-t1d/16254/Tune in for an in-depth review of a recent paper focusing on the heterogeneity and endotypes in type 1 diabetes.Addressing the Unique Challenges for Elderly Patients with Diabetes
https://reachmd.com/programs/diabetes-discourse/addressing-the-unique-challenges-for-elderly-patients-with-diabetes/5568/The prevalence of type 2 diabetes increases with age, with an estimated 8.6 million Americans over the age of 60 diagnosed with diabetes, and a growing number at-risk for developing diabetes with age. Our elderly face unique diabetes management challenges. Join host Dr. Steven Edelman and his guest,The Macrogenics of Diabetes
https://reachmd.com/programs/clinicians-roundtable/the-macrogenics-of-diabetes/1768/How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease phyFostering a "Back to Basics" Model in Type 2 Diabetes Care
https://reachmd.com/programs/diabetes-discourse/fostering-a-back-to-basics-model-for-type-2-diabetes-care/7584/For clinicians managing patients with T2DM, the clinical landscape for standards of care, diagnostic methods and techniques, and treatment options has become increasingly complex. Yet despite this challenge in keeping up to date with the latest recommendations, updated practice guidelines have alsoResults of ADVANCE Diabetes Trial
https://reachmd.com/programs/lipid-luminations/results-of-advance-diabetes-trial/3822/The ADVANCE Study involved 11,140 high-risk patients with type 2 diabetes. Join host Dr. Larry Kaskel when guest Dr. Eliot Brinton explains the findings from the largest-ever study of treatments for diabetes, which provided no evidence of an increased risk of death among patients receiving aggIn-Line Vasectomy and Vasectomy Reversals
https://reachmd.com/programs/clinicians-roundtable/in-line-vasectomy-and-vasectomy-reversals/2519/Our guest, Dr. Paul Shin prefers to use the in-line vasectomy method on his patients. What is different about this technique and why is it better for the patients? Join host, Dr. Larry Kaskel to learn about in-line vasectomy and also about vasectomy reversal.Is Reversing Retinopathy in Sight?
https://reachmd.com/programs/diabetes-discourse/is-reversing-retinopathy-in-sight/13634/Can this novel technology help us combat diabetes?